Related Articles
ATAD2 is associated with malignant characteristics of pancreatic cancer cells
ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation
Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis
Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer
The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells